Alpelisib administration reduced lymphatic malformations in a mouse model and in patientsFlorence Delestre, Guillaume Canaud, Rubina Cassaca et al.|Science Translational Medicine|2021Cited by 92
Targeted therapy for capillary-venous malformationsLola Zerbib, Guillaume Canaud, Sophia Ladraa et al.|Signal Transduction and Targeted Therapy|2024Cited by 28
First report of successful pregnancies after treatment with alpelisib for PIK3CA-related overgrowth spectrumG Morin, Guillaume Canaud, Antoine Fraissenon et al.|European Journal of Human Genetics|2025Cited by 5
Somatic PIK3R1 mutations in the iSH2 domain are accessible to PI3Kα inhibitionG Morin, Guillaume Canaud, Alexandre P. Garneau et al.|EMBO Molecular Medicine|2025Cited by 2